Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Concord Biotech's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Concord Biotech's Dividend Payout Ratio or its related term are showing as below:
BOM:543960'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.36 Max: 0.46
Current: 0.43
During the past 7 years, the highest Dividend Payout Ratio of Concord Biotech was 0.46. The lowest was 0.26. And the median was 0.36.
BOM:543960's Dividend Payout Ratio is ranked better than 50% of 130
companies
in the Biotechnology industry
Industry Median: 0.43
vs BOM:543960: 0.43
Concord Biotech (BOM:543960) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Concord Biotech Dividend Payout Ratio Related Terms
Concord Biotech Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Concord Biotech's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543960 vs VRTX, REGN, RVMD: Dividend Payout Ratio Comparison
For the Biotechnology subindustry, Concord Biotech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Biotech Dividend Payout Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Concord Biotech's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Concord Biotech's Dividend Payout Ratio falls into.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Concord Biotech's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Biotech (BOM:543960) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Concord Biotech and its competitors. Over the past decade, Concord Biotech's Dividend Payout Ratio has ranged from 0.26 to 0.46. According to the industry distribution chart, Concord Biotech ranks #65 out of 130 companies in the Biotechnology industry, placing it in the top 50%.
Is Concord Biotech's Dividend Payout Ratio too high?
Concord Biotech's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 0.46. Based on the distribution chart, Concord Biotech ranks #65 out of 130 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Concord Biotech has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Concord Biotech's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Concord Biotech ranks #65 out of 130 companies for Dividend Payout Ratio. This puts Concord Biotech in the upper half of its industry. The industry median Dividend Payout Ratio is 0.43. Historically, Concord Biotech's own Dividend Payout Ratio has ranged from 0.26 to 0.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.43, based on 130 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Concord Biotech and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Biotech's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Biotech stock overvalued right now?
Based on GuruFocus' analysis, Concord Biotech (BOM:543960) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,670.27, compared to a current price of ₹1,420.30 — trading 15% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Concord Biotech's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Concord Biotech (BOM:543960), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Biotech (BOM:543960) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Biotech stock appears to be undervalued.
The current stock price of ₹1,420.30 is trading 15% below its estimated GF Value™ of ₹1,670.27.
GuruFocus considers Concord Biotech to be Modestly Undervalued.
Key valuation signals for BOM:543960:
Dividend Payout Ratio: 0.00
GF Value™: ₹1,670.27 vs. price of ₹1,420.30 (15% below fair value)
No single metric tells the full story. See the BOM:543960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Biotech Ltd is a research and development-driven biopharma company that manufactures Active Pharmaceutical Ingredients (API) through fermentation and semi-synthetic process and finished formulations. It is mainly engaged in the business of manufacturing and trading in pharmaceutical products. Geographically Company operates in two segments within India and outside India, having majority revenue from India.
67GF Score
Get the complete analysis for BOM:543960
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543960 has been successfully added to your 
